GR1001511B - Steroid formulations. - Google Patents
Steroid formulations.Info
- Publication number
- GR1001511B GR1001511B GR920100064A GR920100064A GR1001511B GR 1001511 B GR1001511 B GR 1001511B GR 920100064 A GR920100064 A GR 920100064A GR 920100064 A GR920100064 A GR 920100064A GR 1001511 B GR1001511 B GR 1001511B
- Authority
- GR
- Greece
- Prior art keywords
- steroid formulations
- role
- steroid
- formulations
- tipredane
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Μια υδατική σύν?εσις εναιωρήματος η οποία περιέχει, ως δραστικόν συστατικόν, τιπρεδάνη. Η σύν?εσις είναι χρήσιμος δια την ?εραπευτικήν αγωγήν καταστάσεων της ρινός εις τις οποίες αλλεργικές ή ανοσοποιητικές αντιδράσεις παίζουν ένα σημαντικό ρόλο (ρόλο συμβολής). ωAn aqueous suspension composition containing, as active ingredient, tipredane. The composition is useful for the treatment of nasal conditions in which allergic or immune reactions play an important role (contributing role). ω
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919103824A GB9103824D0 (en) | 1991-02-23 | 1991-02-23 | Formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR1001511B true GR1001511B (en) | 1994-02-28 |
Family
ID=10690478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR920100064A GR1001511B (en) | 1991-02-23 | 1992-02-18 | Steroid formulations. |
Country Status (13)
| Country | Link |
|---|---|
| CN (1) | CN1065010A (en) |
| AU (1) | AU1247192A (en) |
| BE (1) | BE1004177A4 (en) |
| FR (1) | FR2673104A1 (en) |
| GB (1) | GB9103824D0 (en) |
| GR (1) | GR1001511B (en) |
| IE (1) | IE920516A1 (en) |
| IL (1) | IL101010A0 (en) |
| IT (1) | IT1254627B (en) |
| MX (1) | MX9200748A (en) |
| PT (1) | PT100150A (en) |
| WO (1) | WO1992014473A1 (en) |
| ZA (1) | ZA921247B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0551626A1 (en) * | 1991-12-19 | 1993-07-21 | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. | Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation |
| US5976573A (en) * | 1996-07-03 | 1999-11-02 | Rorer Pharmaceutical Products Inc. | Aqueous-based pharmaceutical composition |
| JP2005281315A (en) * | 1997-07-02 | 2005-10-13 | Aventis Pharmaceuticals Holdings Inc | Aqueous pharmacological composition |
| TWI243687B (en) * | 1998-04-21 | 2005-11-21 | Teijin Ltd | Pharmaceutical composition for application to mucosa |
| US20030059440A1 (en) * | 1998-09-01 | 2003-03-27 | Tim Clarot | Composition and method for moisturizing nasal tissue |
| AR026073A1 (en) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | PHARMACEUTICAL COMPOSITION AQUATIC CONTAINING CICLESONIDE |
| AR026072A1 (en) * | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | PHARMACEUTICAL COMPOSITION CONTAINING CICLESONIDE FOR MUCOSA APPLICATION |
| DE10064950A1 (en) * | 2000-12-23 | 2002-07-11 | Impetus Ag Basel | Thixotropic nasal spray |
| EP1645266A1 (en) * | 2004-10-08 | 2006-04-12 | Hisamitsu Medical Co., Ltd. | Aqueous suspension for nasal drops |
| EP2057982A1 (en) * | 2007-11-09 | 2009-05-13 | Archimedes Development Limited | Intranasal compositions |
| WO2013049539A1 (en) * | 2011-09-30 | 2013-04-04 | Mcneil-Ppc, Inc. | A method of blocking or trapping allergens |
| CN111787925A (en) * | 2017-10-11 | 2020-10-16 | 生命科学股份有限公司 | N-acetylneuraminic acid compositions and methods of use |
| PH12021551943A1 (en) * | 2019-02-11 | 2022-05-23 | Reckitt Benckiser Health Ltd | Novel composition |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0073026A1 (en) * | 1981-08-20 | 1983-03-02 | E.R. Squibb & Sons, Inc. | 17,17-Bis(substituted thio)-3-ketoandrostenes and pharmaceutical compositions |
| EP0246652A2 (en) * | 1986-05-22 | 1987-11-25 | Syntex Pharmaceuticals International Limited | Aqueous steroid formulations for nasal administration |
| US4868170A (en) * | 1987-11-13 | 1989-09-19 | E. R. Squibb & Sons, Inc. | Steriod lotion formulation |
| WO1991011173A1 (en) * | 1990-02-02 | 1991-08-08 | Fisons Plc | Propellant compositions |
-
1991
- 1991-02-23 GB GB919103824A patent/GB9103824D0/en active Pending
-
1992
- 1992-02-18 GR GR920100064A patent/GR1001511B/en unknown
- 1992-02-18 IE IE051692A patent/IE920516A1/en unknown
- 1992-02-19 IL IL101010A patent/IL101010A0/en unknown
- 1992-02-19 AU AU12471/92A patent/AU1247192A/en not_active Abandoned
- 1992-02-19 WO PCT/GB1992/000290 patent/WO1992014473A1/en not_active Ceased
- 1992-02-20 ZA ZA921247A patent/ZA921247B/en unknown
- 1992-02-21 IT ITMI920393A patent/IT1254627B/en active IP Right Grant
- 1992-02-21 PT PT100150A patent/PT100150A/en not_active Application Discontinuation
- 1992-02-21 MX MX9200748A patent/MX9200748A/en unknown
- 1992-02-21 BE BE9200182A patent/BE1004177A4/en not_active IP Right Cessation
- 1992-02-22 CN CN92101619A patent/CN1065010A/en active Pending
- 1992-02-24 FR FR9202105A patent/FR2673104A1/en not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0073026A1 (en) * | 1981-08-20 | 1983-03-02 | E.R. Squibb & Sons, Inc. | 17,17-Bis(substituted thio)-3-ketoandrostenes and pharmaceutical compositions |
| EP0246652A2 (en) * | 1986-05-22 | 1987-11-25 | Syntex Pharmaceuticals International Limited | Aqueous steroid formulations for nasal administration |
| US4868170A (en) * | 1987-11-13 | 1989-09-19 | E. R. Squibb & Sons, Inc. | Steriod lotion formulation |
| WO1991011173A1 (en) * | 1990-02-02 | 1991-08-08 | Fisons Plc | Propellant compositions |
Non-Patent Citations (1)
| Title |
|---|
| CLAIMS SEARCHED: ALL * |
Also Published As
| Publication number | Publication date |
|---|---|
| BE1004177A4 (en) | 1992-10-06 |
| IL101010A0 (en) | 1992-11-15 |
| IE920516A1 (en) | 1992-08-26 |
| CN1065010A (en) | 1992-10-07 |
| AU1247192A (en) | 1992-09-15 |
| IT1254627B (en) | 1995-09-28 |
| ITMI920393A1 (en) | 1993-08-21 |
| ITMI920393A0 (en) | 1992-02-21 |
| ZA921247B (en) | 1992-10-28 |
| FR2673104A1 (en) | 1992-08-28 |
| PT100150A (en) | 1993-05-31 |
| MX9200748A (en) | 1992-10-01 |
| WO1992014473A1 (en) | 1992-09-03 |
| GB9103824D0 (en) | 1991-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2179040T3 (en) | USE OF 5-FLUORO-2'-DESOXI-3'-THIACITIDINE FOR THE TREATMENT OF HEPATITIS B. | |
| FI862011A0 (en) | THERAPEUTIC NUCLEOSIDER. | |
| ATE73331T1 (en) | USE OF TETRAHYDROBIOPTERINS TO MANUFACTURE A MEDICATION FOR THE TREATMENT OF CHILDREN'S AUTISM. | |
| SE8804629D0 (en) | NEW THERAPEUTICALLY ACTIVE COMPOUNDS | |
| SE7903186L (en) | CEREBRAL EFFICIENT | |
| ES2057604T3 (en) | R-ENANTIOMER OF N-PROPARGIL-1-AMINOINDANE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT. | |
| NO970051L (en) | Aqueous risperidone formulations | |
| NO163776C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOQUINOXALINES. | |
| NO173998C (en) | Analogous Procedures for Preparing Therapeutically Active Benzimidazole Derivatives | |
| BR0015416A (en) | Compositions containing tetraenoic hydroxyieic acid derivatives and methods of use in the treatment of dry eye disorders | |
| BR9709845B1 (en) | aqueous insulin preparation, parenteral pharmaceutical formulation, and process for enhancing the chemical stability of an insulin preparation. | |
| NO865079L (en) | PROCEDURE FOR THE PREPARATION OF STABILIZED HUMAN WEB PLASMINOGEN ACTIVATOR PREPARATIONS. | |
| GR1001511B (en) | Steroid formulations. | |
| AU7533091A (en) | N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases, their preparation and use | |
| DE3583916D1 (en) | AQUEOUS MEDICINE FORMULATIONS OF PIROXICAMMONOHYDRATE. | |
| SE8404065D0 (en) | NOVEL BIOLOGICALLY ACTIVE COMPOUNDS | |
| IT1224405B (en) | ACTIVE COMPOUNDS ON THE CARDIOVASCULAR SYSTEM | |
| SE8600658D0 (en) | NOVEL COMPOSITION OF MATTER | |
| IT1240683B (en) | PHARMACEUTICAL COMPOSITION CONTAINING EGF | |
| ATE204752T1 (en) | THERAPEUTIC USES OF 2',5'-OLIGOADENYLATE DERIVATIVES | |
| DE59101404D1 (en) | Topical preparations. | |
| FI932654A0 (en) | Hydroxamsyraderivat, som hindrar lipoxigenas | |
| DE3778642D1 (en) | THERAPEUTIC FOR TREATMENT OF STOMACH. | |
| DE59101818D1 (en) | Pharmaceutical preparation containing stigmasta-4-en-3-one and their use. | |
| PT1232173E (en) | FUSIDIC ACID DERIVATIVES |